Literature DB >> 20709173

Activation by phosphorylation and purification of human c-Jun N-terminal kinase (JNK) isoforms in milligram amounts.

Anastasia F Thévenin1, Chati L Zony, Brian J Bahnson, Roberta F Colman.   

Abstract

c-Jun N-terminal kinases (JNKs) are part of the mitogen-activated protein kinase (MAPK) signaling cascade. They are activated through dual phosphorylation of two residues in the activation loop, a threonine and a tyrosine, by MAP2 kinases (MKK4 and 7) in response to various extracellular stresses such as UV or osmotic shock, as well as by cytokines and growth factors. Only small amounts of phosphorylated, active JNKs have previously been produced because of difficulties in expressing these phosphorylated kinases in Escherichia coli, which lack the appropriate upstream kinases. We have now established a novel activation and purification method that allows for reproducible production of milligram amounts of active, phosphorylated JNKs suitable for a variety of enzymatic, biophysical and structural characterizations. We utilize N-terminally His-tagged MKK4 that is coexpressed in E. coli with a constitutively active form of MEKK1. This phosphorylated, active His-MKK4 is purified by Ni-NTA chromatography and used to phosphorylate milligram amounts of three different isoforms of human JNKs (JNK1α1, JNK1α2 and JNK2α2) that had separately been expressed and purified from E. coli in their inactive forms. These in vitro activated JNKs are phosphorylated on both residues (T183, Y185) in their activation loops and are active towards their substrate, ATF2.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20709173      PMCID: PMC2991412          DOI: 10.1016/j.pep.2010.08.002

Source DB:  PubMed          Journal:  Protein Expr Purif        ISSN: 1046-5928            Impact factor:   1.650


  26 in total

1.  Identification of a specific domain responsible for JNK2alpha2 autophosphorylation.

Authors:  Jian Cui; Marina Holgado-Madruga; Wanwen Su; Hiromasa Tsuiki; Philip Wedegaertner; Albert J Wong
Journal:  J Biol Chem       Date:  2005-01-06       Impact factor: 5.157

Review 2.  Crystallization of MAP kinases.

Authors:  Seung-Jae Lee; Tianjun Zhou; Elizabeth J Goldsmith
Journal:  Methods       Date:  2006-11       Impact factor: 3.608

3.  Gene splicing and mutagenesis by PCR-driven overlap extension.

Authors:  Karin L Heckman; Larry R Pease
Journal:  Nat Protoc       Date:  2007       Impact factor: 13.491

4.  The crystal structure of JNK2 reveals conformational flexibility in the MAP kinase insert and indicates its involvement in the regulation of catalytic activity.

Authors:  David Shaw; Sandra M Wang; Armando G Villaseñor; Stan Tsing; David Walter; Michelle F Browner; Jim Barnett; Andreas Kuglstatter
Journal:  J Mol Biol       Date:  2008-09-10       Impact factor: 5.469

5.  Crystal structure of JNK3: a kinase implicated in neuronal apoptosis.

Authors:  X Xie; Y Gu; T Fox; J T Coll; M A Fleming; W Markland; P R Caron; K P Wilson; M S Su
Journal:  Structure       Date:  1998-08-15       Impact factor: 5.006

6.  Impaired synergistic activation of stress-activated protein kinase SAPK/JNK in mouse embryonic stem cells lacking SEK1/MKK4: different contribution of SEK2/MKK7 isoforms to the synergistic activation.

Authors:  T Wada; K Nakagawa; T Watanabe; G Nishitai; J Seo; H Kishimoto; D Kitagawa; T Sasaki; J M Penninger; H Nishina; T Katada
Journal:  J Biol Chem       Date:  2001-06-19       Impact factor: 5.157

7.  Production of active recombinant mitogen-activated protein kinases through transient transfection of 293T cells.

Authors:  Qun Zhao; Peili Chen; Mary E Manson; Yusen Liu
Journal:  Protein Expr Purif       Date:  2005-10-10       Impact factor: 1.650

8.  Expression and characterization of MAP kinases in bacteria.

Authors:  Charles J Heise; Melanie H Cobb
Journal:  Methods       Date:  2006-11       Impact factor: 3.608

9.  Kinetic characterization of human JNK2alpha2 reaction mechanism using substrate competitive inhibitors.

Authors:  Linghao Niu; Kung-Ching Chang; Stacy Wilson; Patricia Tran; Fengrong Zuo; David C Swinney
Journal:  Biochemistry       Date:  2007-03-31       Impact factor: 3.162

10.  Mechanistic characterization for c-jun-N-Terminal Kinase 1alpha1.

Authors:  Brian Ember; Philip LoGrasso
Journal:  Arch Biochem Biophys       Date:  2008-06-05       Impact factor: 4.013

View more
  6 in total

1.  Laminin-α1 LG4-5 domain binding to dystroglycan mediates muscle cell survival, growth, and the AP-1 and NF-κB transcription factors but also has adverse effects.

Authors:  Yan Wen Zhou; Jesus Munoz; Daifeng Jiang; Harry W Jarrett
Journal:  Am J Physiol Cell Physiol       Date:  2011-12-07       Impact factor: 4.249

2.  GST pi modulates JNK activity through a direct interaction with JNK substrate, ATF2.

Authors:  Anastasia F Thévenin; Chati L Zony; Brian J Bahnson; Roberta F Colman
Journal:  Protein Sci       Date:  2011-03-23       Impact factor: 6.725

3.  Hypersensitivity of the hippocampal CA3 region to stress-induced neurodegeneration and amyloidogenesis in a rat model of surgical menopause.

Authors:  Quan-Guang Zhang; Rui-Min Wang; Erin Scott; Dong Han; Yan Dong; Jing-Yi Tu; Fang Yang; Gangadhara Reddy Sareddy; Ratna K Vadlamudi; Darrell W Brann
Journal:  Brain       Date:  2013-03-09       Impact factor: 13.501

4.  PPA1 regulates tumor malignant potential and clinical outcome of colon adenocarcinoma through JNK pathways.

Authors:  Ping Wang; Yi Zhou; Qi Mei; Jing Zhao; Liu Huang; Qiang Fu
Journal:  Oncotarget       Date:  2017-04-24

5.  Escitalopram Ameliorates Cognitive Impairment in D-Galactose-Injected Ovariectomized Rats: Modulation of JNK, GSK-3β, and ERK Signalling Pathways.

Authors:  Weam W Ibrahim; Noha F Abdelkader; Hesham M Ismail; Mahmoud M Khattab
Journal:  Sci Rep       Date:  2019-07-11       Impact factor: 4.379

6.  Phosphokinome Analysis of Barth Syndrome Lymphoblasts Identify Novel Targets in the Pathophysiology of the Disease.

Authors:  Prasoon Agarwal; Laura K Cole; Abin Chandrakumar; Kristin D Hauff; Amir Ravandi; Vernon W Dolinsky; Grant M Hatch
Journal:  Int J Mol Sci       Date:  2018-07-12       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.